Biography
In research, Oskowitz is interested in using stem cells to develop novel treatments for aortic aneurysms.
Oskowitz earned a master's degree in public health from Dartmouth College. He earned his medical and doctoral degrees at Tulane University. He completed his general surgery residency at the University of California, Los Angeles, where he served as chief resident. He also completed a fellowship in vascular surgery at UCLA.
Education
Institution | Degree | Dept or School | End Date |
---|---|---|---|
UCLA Medical Center | Fellowship | Vascular surgery | 2016 |
UCLA Medical Center | Residency | 2014 | |
Tulane University School of Medicine | 2009 |
Board Certifications
American Board of Surgery, General Surgery
Clinical Expertise
Abdominal Aortic Aneurysm
Aortic Dissection
Aortic Arch Aneurysms
Carotid Artery Disease
Complex Limb Revascularization
Complex Endovascular Aortic Repair
Dialysis Access
Endovascular Aneurysm Repair
Marfan Syndrome
Mesenteric Artery Disease
Peripheral Artery Disease
Thoracic Aortic Aneurysm
Venous Obstructive Disease
Visceral Artery Aneurysm
Foreign Languages Spoken
Research Narrative
Dr. Oskowitz is interested in developing novel treatments for Aortic Aneurysms using stem cells. His is currently studying the molecular mechanisms that govern the therapeutic benefits of stem cells while developing unique ways to utilize cell based therapy.
Research Interests
Aortic Aneurysms
Stem Cell Biology
Biologic Scaffolds and Stents
Research Pathways
Publications
- PET Imaging Using 89Zr Labeled StarPEG Nanocarriers Reveals Heterogeneous Enhanced Permeability and Retention (EPR) in Prostate Cancer.| | PubMed
- 3D small-scale dosimetry and tumor control of 225Ac radiopharmaceuticals for prostate cancer.| | PubMed
- Vein Distensibility is Superior to Vein Diameter for Predicting Unassisted Maturation of Arteriovenous Fistulae.| | PubMed
- Prostate-Specific Membrane Antigen Targeted StarPEG Nanocarrier for Imaging and Therapy of Prostate Cancer.| | PubMed
- Vein Compliance is Superior to Vein Diameter for Predicting Unassisted AVF Maturation.| | UCSF Research Profile
- Patients with abdominal aortic aneurysms have reduced levels of microRNA 122-5p in circulating exosomes.| | PubMed
- A Chimeric Antigen Receptor Targeting Malonaldehyde-modified Low-density lipoprotein Cholesterol Activates Regulatory T Cells in the Presence of Human Atherosclerotic Plaque.| | UCSF Research Profile
- Regulatory T Cells Suppress Aortic Aneurysm Growth in Mice through Local Tissue Changes and Lymph Node Colonization.| | UCSF Research Profile
- Abstract 124: Regulatory T Cells Suppress Aortic Aneurysm Growth In Mice Through Local Tissue Changes And Lymph Node Colonization.| | UCSF Research Profile
- Abstract 128: A Chimeric Antigen Receptor Targeting MDA-LDL Activates Regulatory T Cells In The Presence Of Human Atherosclerotic Plaque.| | UCSF Research Profile
- Toward endovascular treatment of type A aortic dissection with smaller landing zones and more patient eligibility.| | PubMed
- Abstract 15839: Patients With Abdominal Aortic Aneurysms Have Reduced Levels of MicroRNA 122-5p in Circulating Exosomes.| | UCSF Research Profile
- Impact of the coronavirus disease 2019 pandemic on an academic vascular practice and a multidisciplinary limb preservation program.| | PubMed
- Toward Endovascular Treatment of Type A Aortic Dissection: Smaller Landing Zones, More Patient Eligibility.| | UCSF Research Profile
- Natural history of acute pediatric iliofemoral artery thrombosis treated with anticoagulation.| | PubMed
- Circulating exosomes from patients with peripheral artery disease influence vascular cell migration and contain distinct microRNA cargo.| | PubMed
- Functional outcomes of arteriovenous fistulas recruited with regional anesthesia.| | PubMed
- Natural History of Acute Pediatric Iliofemoral Artery Thrombosis Treated With Antithrombotic Therapy.| | UCSF Research Profile
- Arteriovenous Fistulas Recruited With Regional Anesthesia Have Comparable Functional Outcomes.| | UCSF Research Profile
- Abstract 109: Exosomes from Mesenchymal Stem Cells Suppress Aortic Elastin Induced Inflammation in Macrophages.| | UCSF Research Profile
- Infrarenal aortic repair with or without false lumen intentional placement of endografts for hybrid management of complex aortic dissection.| | PubMed
- Contemporary outcomes after venography-guided treatment of patients with May-Thurner syndrome.| | PubMed
- Infrarenal Aortic Repair With or Without False Lumen Intentional Placement of Endografts for Hybrid Management of Complex Aortic Disease.| | UCSF Research Profile
- Contemporary Outcomes of Elective Iliac Vein Stenting in Chronic Venous Occlusive Disease.| | UCSF Research Profile
- Contemporary Outcomes Following Imaging-Guided Treatment of Patients With May-Thurner Syndrome.| | UCSF Research Profile
- Hybrid treatment of aortic arch aneurysms.| | PubMed
- Drosha regulates hMSCs cell cycle progression through a miRNA independent mechanism.| | PubMed
- Activation of autophagy in mesenchymal stem cells provides tumor stromal support.| | PubMed
- Human mesenchymal stromal cells (MSCs) reduce neointimal hyperplasia in a mouse model of flow-restriction by transient suppression of anti-inflammatory cytokines.| | PubMed
- Serum-deprived human multipotent mesenchymal stromal cells (MSCs) are highly angiogenic.| | PubMed
- Epigenetic reprogramming of IGF1 and leptin genes by serum deprivation in multipotential mesenchymal stromal cells.| | PubMed
- Human multipotent stromal cells from bone marrow and microRNA: regulation of differentiation and leukemia inhibitory factor expression.| | PubMed
- CREB phosphorylation and c-Fos expression in the hippocampus of rats during acquisition and recall of a socially transmitted food preference.| | PubMed